PARR MCKNIGHT WEALTH MANAGEMENT GROUP, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 2026926
MINNEAPOLIS, MN
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$267,967
-$27,636 QoQ
Shares Held
2,121
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,734
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARR MCKNIGHT WEALTH MANAGEMENT GROUP, LLC holds $42,908,567 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
52,427 | $13,314,885 | |
| 2 | LLY |
ELI LILLY & Co
|
7,918 | $9,497,087 | |
| 3 | AMGN |
Amgen Inc
|
14,946 | $5,412,245 | |
| 4 | ABBV |
AbbVie Inc.
|
15,689 | $3,947,979 | |
| 5 | AZN |
Astrazeneca PLC
|
20,406 | $3,869,385 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,951 | $3,334,703 | |
| 7 | NVS |
Novartis AG
|
18,651 | $2,922,984 | |
| 8 | NVO |
Novo Nordisk A S
|
7,120 | $341,332 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,967 | 2,121 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $295,603 | 2,121 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $260,331 | 2,121 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $235,431 | 2,121 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $235,155 | 2,121 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $237,658 | 2,121 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||